No phaseCompleted

Cognitive Training in Survivors of Covid-19: A Randomized Trial

Sponsor
Vanderbilt University Medical Center (Academic or other)
Enrolment
83 enrolled
Conditions
Covid19; Cognitive Impairment
Interventions
AKL-T01; Control Group
Ages
adults, older adults
Registry
NCT04956887

From the registry

Preliminary evidence suggests that cognitive impairment is a common outcome experienced by individuals surviving Covid-19 (1-5). Cognitive impairment following Covid-19 which leads to critical illness is not surprising and perhaps even expected. However, significant cognitive deficits appear to be common even among individuals testing positive for Covid-19 who were never hospitalized. Questions exist regarding the mechanisms of the aforementioned cognitive impairment. The association between COVID-19 and brain dysfunction is not surprising since SARS-CoV has been found in the brain and because Coronaviridaes (CoVs) have been associated with central nervous system (CNS) diseases such as acute viral encephalopathy, acute disseminated encephalomyelitis, and multiple sclerosis (6-11).The possible brain entry routes for CoVs include either direct intranasal access to the brain via olfactory nerves or indirect access by crossing the blood-brain barrier (BBB) via hematogenous or lymphatic spread (9).

Primary outcomes

  • Improve cognition
Full record on ClinicalTrials.gov